Emerging Longevity Ventures logo

Emerging Longevity Ventures

North America, Florida, United States, West Palm Beach

Description

Emerging Longevity Ventures is a venture capital firm.

Investor Profile

Emerging Longevity Ventures has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Seed (100%)

Country Focus

  • United Kingdom (60%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Emerging Longevity Ventures frequently co-invest with?

Infinita Fund
North America, Islas de la Bahia, Honduras, Roatán
Co-Investments: 1
Longevitytech.fund
North America, Florida, United States, Boca Raton
Co-Investments: 2
TI
Asia, Shanghai, China, Shanghai
Co-Investments: 3
LV
North America, Connecticut, United States, Norwalk
Co-Investments: 1
VitaDAO
North America, Ontario, Canada, Ottawa
Co-Investments: 1
Healthspan Capital
North America, California, United States, El Cerrito
Co-Investments: 1
1517 Fund
North America, California, United States, Oakland
Co-Investments: 1
QantX
Europe, Devon, United Kingdom, Exeter
Co-Investments: 2
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 2
R42 Group
North America, California, United States, Stanford
Co-Investments: 3

Which angels does Emerging Longevity Ventures often collaborate with?

JM
Europe, Isle of Man
Shared Deals: 1
Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
KP
North America, California, United States, San Francisco
Shared Deals: 1
TE
North America, Massachusetts, United States, Boston
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Emerging Longevity Ventures?

ImmuneAGE Bio is a drug discovery platform focused on rejuvenating the immune system.

BiotechnologyHealth Care
SeedJul 12, 2024
Amount Raised: $2,000,000
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedMar 18, 2024
Amount Raised: $4,708,943
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedJun 9, 2022
Amount Raised: $2,498,545
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedMar 5, 2021
Amount Raised: $1,798,591
Repair Biotechnologies

Syracuse, New York, United States

Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform.

BiotechnologyHealth CareMedical
SeedMay 7, 2019
Amount Raised: $2,150,000

Find More Investors Like Emerging Longevity Ventures

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Emerging Longevity Ventures | Pipeseed